Sandbox/osteo: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 91: Line 91:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nafcillin]] 2 gm IV q4h''''' <br> OR <br> ▸ '''''[[Oxacillin]] 2 gm IV q4h'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nafcillin]] 2 gm IV q4h''''' <br> OR <br> ▸ '''''[[Oxacillin]] 2 gm IV q4h'''''
|-
|-
|}
|}
|}
|}
|}


<br><br><br><br>
<br>
<br><br><br><br>
<br><br><br><br>
 
 
 
===Specific Therapy===
===Specific Therapy===


Line 175: Line 171:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Levofloxacin]] 750 mg IV q24h
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Levofloxacin]] 750 mg IV q24h
|-
|-
|}
|}
|}
|}
|}




 
<br>
<br><br><br><br>
<br><br><br><br>
<br><br><br><br>
 
 
 
==Contiguous Osteomyelitis Without Vascular Insufficiency==
==Contiguous Osteomyelitis Without Vascular Insufficiency==
===Empiric Therapy===
===Empiric Therapy===
Line 262: Line 253:
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Levofloxacin]] 750 mg IV q24h
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Levofloxacin]] 750 mg IV q24h
|-
|-
|}
|}
|}
|}
|}

Latest revision as of 13:33, 22 May 2014

Hematogenous Osteomyelitis

Empiric Therapy

▸ Click on the following categories to expand treatment regimens.

Age

  ▸  Newborn (<4 months)

  ▸  Children (>4 months) - Adults

  ▸  Adult (>21 years)

Staph aureus, gram-negative bacilli, group B strept
Preferred Regimen
Vancomycin 40 mg divided q6-8 hours
PLUS
Ceftazidime 50 mg IV q8h
OR
Cefepime 150 mg IV q8h
Alternative Regimen
Nafcillin
OR
Oxcacillin 37 mg q6h
PLUS
Ceftazidime 2 gm IV q8h
OR
Cefepime 2 gm IV q12h
Staph aureus, group A strept, gram-negative bacilli
Preferred Regimen
Vancomycin 40 mg divided q6-8 hours
PLUS
Ceftazidime 50 mg IV q8h
OR
Cefepime 150 mg IV q8h
Alternative Regimen
Nafcillin
OR
Oxcacillin 37 mg q6h
PLUS
Ceftazidime 2 gm IV q8h
OR
Cefepime 2 gm IV q12h
Staph aureus (most common)
Preferred Regimen
Vancomycin 1 gm IV q12h, if over 100 kg, 1.5 gm IV q12h
Alternative Regimen
Nafcillin 2 gm IV q4h
OR
Oxacillin 2 gm IV q4h


Specific Therapy

▸ Click on the following categories to expand treatment regimens.

Specific Etiology

  ▸  Methicillin-sensitive S.aureus

  ▸  Methicillin-resistant S.aureus

  ▸  Salmonella; GN bacilli

MSSA
Preferred Regimen
Nafcillin 2 gm IV q4h
OR
Oxacillin 2 gm IV q4h
OR
Cefazolin IV q8h
Alternative Regimen
Vancomycin 1 gm q12h IV; if over 100 kg, 1.5 gm IV q12h
MRSA
Preferred Regimen
Vancomycin 1 gm q12h IV
Alternative Regimen
Linezolid 600 mg q12h IV/po
±
Rifampin 300 mg po/IV bid
Salmonella (Gram-negative bacilli)
Preferred Regimen
Ciprofloxacin 400 mg IV q12h
Alternative Regimen
Levofloxacin 750 mg IV q24h



Contiguous Osteomyelitis Without Vascular Insufficiency

Empiric Therapy

▸ Click on the following categories to expand treatment regimens.

Specific Etiology

  ▸  Methicillin-sensitive S.aureus

  ▸  Methicillin-resistant S.aureus

  ▸  Salmonella; GN bacilli

MSSA
Preferred Regimen
Nafcillin 2 gm IV q4h
OR
Oxacillin 2 gm IV q4h
OR
Cefazolin IV q8h
Alternative Regimen
Vancomycin 1 gm q12h IV; if over 100 kg, 1.5 gm IV q12h
MRSA
Preferred Regimen
Vancomycin 1 gm q12h IV
Alternative Regimen
Linezolid 600 mg q12h IV/po
±
Rifampin 300 mg po/IV bid
Salmonella (Gram-negative bacilli)
Preferred Regimen
Ciprofloxacin 400 mg IV q12h
Alternative Regimen
Levofloxacin 750 mg IV q24h